Roivant Sciences Ltd. stock is up 8.68% since 30 days ago. The next earnings date is Feb 12, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 November’s closed higher than October. In the last 10 Unusual Options Trades, there were 2 PUTs, 8 CALLs. 100% of analysts rate it a buy.
Date & Time | Expiration Date | Strike Price | Trade Type | Size | Open Interest |
---|---|---|---|---|---|
07 Nov 20:06 | 19 Jan, 2024 | 10.00 | 338 | ||
09 Nov 15:02 | 15 Dec, 2023 | 10.00 | 2547 | ||
09 Nov 16:44 | 17 Jan, 2025 | 12.50 | 2 | ||
09 Nov 20:55 | 17 May, 2024 | 10.00 | 187 | ||
10 Nov 16:46 | 17 May, 2024 | 10.00 | 687 | ||
14 Nov 15:01 | 19 Jan, 2024 | 10.00 | 110 | ||
15 Nov 17:43 | 15 Dec, 2023 | 10.00 | 3462 | ||
20 Nov 20:37 | 15 Dec, 2023 | 10.00 | 3451 | ||
22 Nov 18:07 | 16 Feb, 2024 | 15.00 | 9215 | ||
28 Nov 17:28 | 16 Jan, 2026 | 10.00 | 200 |
Roivant Sciences Ltd. is a biopharmaceutical and healthcare technology company that researches and develops medicines. The company was founded in 2014 and is based in London, the United Kingdom.